IP Library Granted Patent US 11,590,341
Granted Patent B2
US 11,590,341 · App. 17/491,313 · Granted Feb 28, 2023

Vagal nerve stimulation therapy

Inventors: J. P. Errico (Palm Beach Gardens, FL); Bruce J. Simon (Mountain Lakes, NJ); Peter Staats (Atlantic Beach, FL)
Assignee: ELECTROCORE, INC
A61N1/0456A61N1/0492A61N1/36007A61N1/36021A61N1/36034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,590,341
App. No.
17/491,313
Granted
Feb 28, 2023
Kind
B2
Abstract

Devices, systems and methods are provided for treating post-operative symptoms following major surgery and/or for treating patients in critical or intensive care. A method includes positioning a contact surface of a device in contact with an outer skin surface of patient and applying an electrical impulse transcutaneously from the device through the outer skin surface of the patient to a vagus nerve in the patient for about 60 seconds to about 5 minutes. The electrical impulse is sufficient to modify the vagus nerve such that the symptoms are reduced. A stimulation protocol is provided that includes two or more doses administered per day for a period of time sufficient to relieve the symptoms. The doses may be administered before and after the patient's surgery, or while the patient is being treating in intensive care.

Claims (15)

1. A method for treating post-operative symptoms in a patient, the method comprising:

attaching a patch to the outer skin surface of a neck of the patient, wherein the patch comprises one or more electrodes;

generating an electrical impulse with a device;

wirelessly transmitting the electrical impulse from the device to the one or more electrodes;

the electrical impulse transcutaneously from the one or more electrodes through the outer skin surface of the patient to a vagus nerve in the patient according to a stimulation protocol that includes at least two doses administered each day for a plurality of days, wherein the doses each have a duration of about sixty seconds to about 5 minutes; and

wherein the electrical impulse is sufficient to modify the vagus nerve such that symptoms of intraperitoneal or retroperitoneal inflammation are reduced.

2. The method of claim 1 , wherein the electrical impulse comprises pulses having a frequency of about 1 kHz to about 20 kHz.

3. The method of claim 2 , wherein the electrical impulse comprises bursts of pulses, with each burst having a frequency of about 1 to about 100 bursts per second and each pulse has a duration of about 50 to about 1000 microseconds in duration.

4. The method of claim 3 , wherein the bursts each comprise about 2 to 20 pulses and the bursts are separated by an inter-burst period that comprises zero pulses.

5. The method of claim 1 , wherein at least one of the doses is administered to the patient prior to a surgery.

6. The method of claim 5 , wherein at least of the doses is administered to the patient after the surgery.

7. The method of claim 1 , wherein the doses are separated by a time frame of about 1 hour to about 12 hours.

8. The method of claim 1 , wherein the stimulation protocol comprises 2 to 12 treatments/day.

9. The method of claim 1 , wherein the electrical impulse is sufficient to inhibit a release of a pro-inflammatory cytokine.

10. The method of claim 1 , wherein the electrical impulse is sufficient to reduce post-operative pain.

Assignments (2)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: ERRICO, JOSEPH P.; SIMON, BRUCE J.; STAATS, PETER
To: ELECTROCORE, INC.
Reel/Frame 057662/0721 →
Continuity (4)
Continuation In Part 16838953 · Apr 2, 2020
Continuation In Part 16229299 · Dec 21, 2018
Provisional Application 62609807 · Dec 22, 2017
Related Publication 20220062622A1 · Mar 3, 2022